论文部分内容阅读
目的探讨灯盏花素联合复方氨基酸治疗眩晕症的疗效。方法收集2009年1月-2011年12月98例眩晕症原患者,按不同治疗方法分为观察组55例,对照组43例,观察组采用灯盏花素联合复方氨基酸治疗,对照组采用单纯灯盏花素治疗,对比两组患者的治疗效果。结果观察组临床疗效明显优于对照组,两组患者平均眩晕缓解时间、5天症状缓解率,住院时间及复发率比较,差异有统计学意义(P<0.05)。结论灯盏花素联合复方氨基酸治疗眩晕症疗效肯定,症状缓解快,住院时间明显缩短,复发率低,优于单纯灯盏花素治疗,值得临床推广应用。
Objective To investigate the efficacy of breviscapine combined with compound amino acids in the treatment of vertigo. Methods A total of 98 patients with vertigo from January 2009 to December 2011 were collected and divided into observation group (55 cases) and control group (43 cases). The observation group was treated with breviscapine combined with compound amino acid. The control group was treated with simple lamp Treatment of florin, compared with the treatment effect of two groups of patients. Results The clinical efficacy of the observation group was significantly better than that of the control group. The mean vertigo relief time, symptom relief rate, hospitalization time and recurrence rate on the 5th day were significantly different between the two groups (P <0.05). Conclusion Breviscapine combined with compound amino acids for the treatment of vertigo is positive, the symptoms relieved quickly, hospitalization time was significantly shortened, the recurrence rate is lower, better than simple Breviscapine treatment, worthy of clinical application.